FOR PATIENTS AND VISITORS: You must self-screen and wear a mask if entering the Emergency Department, waiting areas, patient rooms or other patient care areas. All Unity Health Toronto spaces are mask-friendly. Learn more about our current guidelines for visitors.

Kim Connelly

Division Head, Division of Cardiology, St. Michael’s Hospital
Department: Medicine,
Division: Cardiology,
Clinical Interests: Echocardiography, MRI, sports cardiology, diabetes, obesity, ventricular remodeling, valvular disease, AF and athletes
Academic Interests: Cardiovascular physiology, in particular the role of prosclerotic cytokines and extracellular matrix upon cardiac diastolic function in disease states such as hypertension and diabetes

Executive Director, Keenan Research Centre for Biomedical Science, Unity Health
Keenan Chair in Research Leadership
Associate Professor of Medicine, University of Toronto

Dr. Kim Connelly is a Cardiologist and Scientist who is both nationally recognized as an expert in echocardiography, cardiovascular MRI and the impact of diabetes upon cardiac function and ventricular remodeling. Dr. Connelly runs a basic research laboratory at the Keenan Research Centre at St. Michael’s Hospital where he focuses upon basic mechanisms of disease – primarily around the role of pathological extracellular matrix accumulation with a focus upon integrin biology and translating discoveries into therapies in humans.

He has an H-index of 59 and i10-index of 187 (Google scholar), and his work has been cited >11800 times, with publications in journals such as the NEJM, Circulation, Journal of the American college of Cardiology, Circulation Research, Diabetes, Cell Metabolism and Lancet Endocrinology and Diabetes. His work is diverse covering clinical guidelines statements, clinical trials, and preclinical studies along the themes of ventricular remodeling, diabetes, magnetic resonance imaging and echocardiography. He is a member of the editorial board of various journals such as The Canadian Journal of Cardiology and Cardiovascular Diabetology. He has received funding from the Heart and Stroke Foundation Canada, CIHR, Canadian Foundation of Innovation, Ministry of Ontario and industry sources, totally >$5 million as principal investigator. As a co-investigator, he has been part of >$20 million in funding, from the Ministry of Ontario, HSF, CIHR, CFI and industry sources.

Dr. Connelly has been recognized for his contributions to science by being awarded a HSF clinician scientist award, a CIHR New Investigator Award, an Early Researcher Award from the Ministry of Ontario, the SC Verma award and the Insulin 100 emerging leader award to celebrate 100 years since the discovery of insulin at University of Toronto, as well as Canadian Cardiovascular Congress YIA 2012. He is past chair of the Canadian Cardiovascular guideline and was chair of the macrovascular complication section for Diabetes Canada CPG 2018.

Dr. Kim Connelly is the executive director of the Keenan Research Centre for Biomedical Science and holds the Keenan Chair in Research Leadership, and is the head of the Division of Cardiology, St. Michael’s hospital, Toronto.

Last updated March 27, 2024